Needham & Company LLC Reiterates “Hold” Rating for Revance Therapeutics (NASDAQ:RVNC)
Needham & Company LLC reiterated their hold rating on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Friday morning,Benzinga reports. A number of other brokerages have also weighed in on RVNC. StockNews.com assumed coverage on Revance Therapeutics in a report on Monday, January 13th. They issued a “hold” […]
More Stories
Employer Health Insurance Costs Rise as Workers Shoulder More of the Bill, Report Says
By Bill Pan Health care costs continued to rise for employers and workers this year, with employees paying more for...
The Color Revolution Comes Home: Ex-USAID Operatives, DSA Networks, and a Playbook Aimed at the American Republic
By Stephen Zogopoulos, USNN World News In the interview titled “DataRepublican: The Democrat Plan For A Color Revolution: Everything You...
Trump Admin Can Detain Illegal Immigrants Without Bond Hearings: Appeals Court
By Zachary Stieber President Donald Trump’s administration can hold illegal immigrants in detention without bond hearings, a full federal appeals...
Florida Mayor Arrested After Authorities Say She Paid Herself and Family State COVID Funds
By Jill McLaughlin State authorities arrested the mayor of the central Florida city of Kissimmee on Oct. 21, charging her...
American Express Laying Off 5 Percent of Workforce
By Andrew Moran American Express said it is laying off about 5 percent of its workforce. The global payment services...
Typhoon Champi Leaves 1 Dead, 350 Injured in Taiwan; Alters US-Japan Military Exercise
By Arthur Zhang Typhoon Champi left one person dead and 350 injured in Taiwan, disrupting air and rail travel and...